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Abstract.  Extracts from BSC-40 cells infected with 
vaccinia recombinants expressing either the yeast 
KEX2 prohormone endoprotease or a human structural 
homologue (fur gene produc0 contained an elevated 
level of a membrane-associated endoproteolytic activ- 
ity that could cleave at pairs of basic amino acids 
(-LysArg- and -ArgArg-). The fur-directed activity (fu- 
fin) shared many properties with Kex2p including ac- 
tivity at pH 7.3 and a requirement for calcium. By 
using antifurin antibodies, immunoblot analysis de- 
tected two furin translation products (90 and 96 kD), 
while immunofluorescence indicated localization to the 
Golgi apparatus. Coexpression of either Kex2p or fu- 
fin with the mouse B-nerve growth factor precursor 
(pro-B-NGF) resulted in greatly enhanced conversion 
of the precursor to mature nerve growth factor. Thus, 
the sequence homology shared by furin and the yeast 
KEX2 prohormone processing enzyme is reflected by 
significant functional homology both in vitro and 
in vivo. 
p 
OSTTRANSLATIONAL  proteolysis is a common mecha- 
nism required for the synthesis of biologically active 
proteins and peptides in all eukaryotes examined, in- 
cluding yeast (21), invertebrates (56), and mammalian cells 
(17, 62). One of the early events in precursor protein matura- 
tion is endoproteolysis at the carboxyl side of pairs of basic 
amino acid sequences (especially  -LysArg- and -ArgArg-). 
This type of endoproteolytic cleavage was initially inferred 
from the sequences of several endocrine and neuroendocrine 
precursor proteins  and was first proposed from studies of 
proinsulin  (9,  64)  and the ACTH/B-endorphin  precursor, 
proopiomelanocortin  (POMC) t  (11). Subsequent  studies 
have revealed a broad spectrum of  precursor proteins that re- 
quire endoproteolysis  at pairs of basic amino acids to yield 
mature peptides,  including  serum factors (3),  viral poly- 
proteins (43, 49, 51, 52), growth factors (24, 26, 58, 75), and 
receptors (76). 
Several activities  capable of cleaving at single or paired 
basic residues in vitro have been proposed as candidates for 
authentic mammalian precursor processing  endoproteases 
(6,  10, 12-16, 25, 31, 32, 39-41, 46, 47). However, none of 
these candidate activities have been shown to be a bona fide 
precursor cleaving endoprotease in vivo. In contrast, genetic 
(33, 37)  and  biochemical (20, 22)  studies  unequivocally 
identified the gene required for excision of the peptide mat- 
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1. Abbreviations  used in this paper:  moi, multiplicity of infection;  NGF, 
nerve growth factor; POMC,  proopiomelanocortin; pro-B-NGE B-nerve 
growth factor precursor; WGA, wheat germ agglutinin. 
ing hormone (a-factor) from its precursor in Saccharomyces 
cerevisiae (baker's yeas0 (for review see reference 21). This 
locus,  the  KEX2 gene,  encodes a  unique  subtilisin-like, 
membrane-bound, calcium-dependent, serine endoprotease 
(Kex2p) specific for cleaving on the carboxyl side of pairs 
of basic residues (-LysArg- and -ArgArg-) (22). 
Several  lines  of evidence suggest  that  the mammalian 
precursor processing endoprotease(s) is functionally  similm 
to Kex2p. The mammalian precursor proalbumin,  for exam- 
pie,  is efficiently converted in vitro to albumin by Kex2p, 
with cleavage at a paired basic amino acid sequence (-Arg- 
Arg-) (2). Furthermore, coexpression of  the KEX2 gene with 
mouse POMC in BSC-40 cells (a line incapable of process- 
ing this peptide precursor) resulted in efficient proteolysis, 
at pairs of basic amino acids, producing authentic pituitary 
peptides,  including ~/-LPH and/~-endorphin 1-31 (68). 
Recently, two human DNA sequences, fur and PC2, have 
been reported which share significant structural homology 
with the KEX2 gene sequence (Fig.  1).  The fur locus was 
initially  identified  by  its  proximity  to  the fes/fps  proto- 
oncogene (53) and its homology to Kex2p was noted subse- 
quently  (23).  The  DNA  sequence of the  entire protein 
predicts  a  translation  product,  furin  (72),  which shares 
nearly 50 % overall sequence identity with Kex2p in the 300- 
residue region comprising the catalytic domain, including 
the  conserved active  site  Asp,  His,  and  Ser.  PC2  was 
identified by amplification of a human insulinoma library by 
the polymerase chain reaction using KEX2-derived primers 
and also shares a high degree of  homology  with Kex2p, espe- 
cially in the active site domains (59).  Both proteins  show 
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Figure 1. Schematic representation of furin, 
Kex2p, and PC2. The amino acids forming 
the  catalytic  triad  in  the  active  site  are 
shown (/9,  aspartate;  H,  histidine; S,  ser- 
ine).  Signal sequences  are  represented  as 
solid black boxes and the subtilisin-like do- 
mains are shown as shaded regions. Hatched 
boxes indicate the putative transmembrane 
domains.  (q~),  potential  sites  for  attach- 
ment of asparagine-linked sugars. See refer- 
ences 72 (furin), 44 (KEX2), and 59 (PC2) 
for predicted protein sequences. 
significantly  greater  homology to  Kex2p  than  to  bacterial 
subtilisins. 
Aside from homology in their catalytic domains, the yeast 
KEX2 gene and human furin eDNA also share very similar 
configurations (Fig.  1). Both proteins have a strongly hydro- 
phobic  NH~-terminal  sequence.  In the case of Kex2p,  this 
segment has been shown to target the protein to the secretory 
pathway,  where it becomes glycosylated (20,  22,  23).  Both 
proteins  also possess  a  single highly hydrophobic  segment 
near  the  COOH-terminus  (44).  In Kex2p,  this  region has 
been shown to be a  transmembrane  domain responsible for 
anchoring the enzyme in the secretory system, probably the 
Golgi  apparatus  (23,  48).  Finally,  both  proteins  contain 
highly charged COOH-terminal tails. 
The  sequence homology and  shared  topology  suggested 
that  the  furin  eDNA  encodes  a  Kex2p-like  protease  that 
could be a  functional human homologue of Kex2p. Here we 
demonstrate  that  indeed the furin cDNA  encodes  a  Golgi- 
localized, membrane-associated,  endoprotease that displays 
a  substrate  specificity, both in vitro and in vivo, similar to 
Kex2p.  Possible functions of furin in mammalian cells are 
discussed. 
Materials and Methods 
Cell Culture 
BSC-40, an African Green monkey kidney epithelial cell line and ART-20, 
a mouse pituitary corticotroph cell line were cultured as described (68, 70). 
HepG2 cells, a hunma hepatoma,  were cultured in MEM containing  10% 
heat inactivated fetal ~:alf  serum (HyClone Laboratories,  Logan, UT) sup- 
plemented  with 0.1 mM pyruvate and 0.1 mM nonessential amino acids 
(Gibco Laboratories,  Grand Island,  NY). 
Vaccinia Virus 
Vaccinia virus strain WR was used in these studies and infections were per- 
formed as described  (68, 70).  To construct  the vaccinia recombinant ex- 
pressing the human furin eDNA (VV:hFUR),  plasmid pBluescript-PACE 
containing the human furin eDNA from which the Y-untranslated region 
was deleted (74) was digested with Sea I and the insert excised by digestion 
with Hinc II and Sma I. Bgl II linkers were ligated on the 2.5-kb insert and 
the fragment was ligated into the vaccinia recombination plasmid,  pVV3, 
which was previously cut with Bgl H. The orientation of the ligated eDNA 
was verified and the resulting plasmid pVV3:hFUR was used for marker 
transfer into vaccinia as previously described (29). To construct a vaccinia 
recombinant  directing  expression  of the  mouse  B-nerve  growth  factor 
precursor (pro-B-NGF) eDNA (VV:mNGF), plasmid pGEM/ngf, contain- 
ing a full-length mouse B-NGF eDNA (71) was digested with Hind HI and 
incubated with Klenow polymerase to generate blunt ends. The linearized, 
blunt-ended fragment was then digested with Bam HI to yield an 820-bp 
insert coding for the shorter transcript of/~-NGF (using the second initiation 
codon) (18). pVV3 plasmid  was digested with Bgl II, incubated with I"4 
DNA polymerase to generate blunt ends, and digested with Barn HI. Vector 
and insert were then ligated and a plasmid containing  the mNGF insert 
(pVV3:mNGF) was used to introduce the mouse NGF eDNA into vaccinia 
virus by standard marker transfer procedures  (29). 
Immunofluorescence 
Cells grown on coverslips were rinsed  in PBS (2.8 mM KC1, 1.5 mM 
KH2PO4, 1.4 mM NaC1, 8 mM Na21-IPO4) with  1 mM MgCI2 (PBS-M) 
and fixed for 15 min in PBS-M containing 3% paraformaldehyde plus 1 mM 
CaCI2. After fixation, cells were permeabilized in 0.2% BSA, 0.1% Triton 
X-100,  1 mM CaCIe,  1 mM MgCI2, and 1 mM MnCI2 in PBS. Next the 
fixed cells were preincubated in 0.1% TX-100 and 2% normal goat serum 
(NGS) to block nonspecitic binding of antibodies. Coverslips were rinsed 
briefly  and  incubated  overnight  at 4°C with rabbit  antifurin  antiserum 
(1:50). The antifurin antibodies were generated against the catalytic domain 
of furin by expression in l~cherichia coil  of amino acids 146-372 of furin 
as a fusion to human superoxide dismutase (74). The furin antiserum was 
preabsorbed with an acetone precipitate of a VV:WT infected BSC-40 cell 
extract and incubated at room temperature for 4 h followed by clarification 
of  the antiserum by centrifugation in a SPIN-X column (Costar, Cambridge, 
MA). After overnight incubation withthe furin antiserum,  coverslips were 
then rinsed in permeabilizing solution, incubated with a biotinylated goat 
anti-rabbit  antiserum (1:200; Vector Laboratories,  Inc., Buflingame, CA) 
for 30 minutes, rinsed and incubated with FITC-conjugated avidin (1:500, 
Vector Laboratories,  Inc.) for 50 min. Coverslips were again rinsed and in- 
cubated with wheat germ agglutinin (WGA; diluted 1:50, Molecular Probes 
Inc., Eugene, OR) for 30 rain at room temperature, rinsed, mounted on mi- 
croscope slides in 50% glycerol,  and viewed with a Laitz Dialux 22 EB 
fluorescent microscope (63 x  objective). 
Cell Fractionation and In Vitro Proteolytic Assays 
BSC-40 cells were grown to comquency  on 100-ram plates in MEM contain- 
ing 10% fetal calf serum. Paralld plates were infected with either VV:WT, 
W:KEX2, or W:hFUR at a multiplicity of infection (moi) of 5. At 18 h 
after infection, cells were chilled on ice, rinsed once in ice-cold PBS-M, 
harvested by scraping in 0.5 rni of 10 mM Hepcs, pH 7.3, and lysed with 
20-30 strokes in a Dounce homogenizer (Kontes Glass Co., Vineland, NJ) 
("~70% total lysis as determined by trypan blue exclusion). Lysates were 
cleared by centrifugation at low speed (1,000 g, 5 rain) to remove cellular 
debris and the crude extract was transferred to an ultracentrifuge tube. After 
centrifugation at 100,000 g for 60 rain,  the supernatant  fraction was re- 
moved and the pellet was resuspcnded in 200/~1 of 10 mM Hepes, pH 7.3. 
For assay, 25/zl was placed in 200/zl of sample buffer (100 mM Hepes, 
pH 7.3, 1%  Triton  X-100,  1 mM CaCI2, 50 #M boc-gly-lys-arg-MCA 
[Peninsula Laboratories,  Inc., Belmont, CA]). Samples were incubated for 
30 rain at 370C and the quantity of liberated amino methyl coumarin was 
determined by fluorimetry (excitation ffi 380k, emission = 460),). Protein 
determinations  were performed  with bicinchoninic acid procedure (61). 
Western Blot 
For immunoblotting, samples containing equivalent amounts of total pro- 
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originally described (54).  Protein was then transferred under electric cur- 
rent (24 V) for 16 h at 4"C to nitrocellulose in transfer buffer (39 mM gly- 
cine, 48 mM Tris, 0.037% SDS, 15 % methanol). The blot was preincubated 
in TBST (10 mM Tris-HCl, pH 8,  150 mM NaC1, 0.05%  Triton X-100, 
0.02% NAN3)  containing  3% dried  nonfat  milk for 50 rain at room  temper- 
attire followed  by incubation  at room  temperature  with primary  antibody 
(rabbit antifurin, diluted 1:8,000) for 3 h. After washing three  times with 
TBST, the blot was incubated with goat anti-rabbit-alkaline  pbosphatase 
and  developed (Promega ProtoBlot Immunoblotting system, Promega 
Corp., Madison, WI). 
Northern Blot 
All RNA manipulations were performed as described (54) and as presented 
in the legend to Fig. 4. 
Immunoprecipitations 
Ceils were grown to confluency in MEM containing 10% fetal calf serum 
in 35-ram, 6-well plates. Parallel wells were infected with VV:NGF (moi 
=  2) and either VV:WT, VV:KEX2 or VV:hFUR (moi =  5, total moi = 
7). After 18 h, ceils were starved for 30 min in MEM (-Met, -Cys) +  10% 
dialyzed  fetal  calf serum, then pulsed  for  3  h  with  [35S]Met,Cys  (100 
t~Ci/well; NEN Express Label, DuPont Co., Wilmington, DE). All further 
treatment of samples was at 4"C.  Medium was harvested and centrifuged 
for 5 rain at 1,500 g, and transferred to a fresh tube.  Samples were then 
centrifuged at 10,000 g  for 20 min and transferred to a fresh tube. A pool 
of four anti-B-NGF rat monoclonal antibodies generated to 2.5S NGF was 
added to each sample and incubated for 2  h.  A  second antibody (rabbit 
anti-rat IgG +  M; Zymed Laboratories Inc., South San Francisco, CA) was 
added and samples were incubated for 1 h.  Finally, protein A-Sepharose 
was added to each sample and incubated for 1 h. The Sepharose beads were 
washed two times with RIPA buffer (1% NP-40, 1% SDS, 1% sodium deoxy- 
cholate [DOt2], 150 mM NaC1, 50 mM Tris-HCl, pH 8) and two times with 
NET-N (150 mM NaCI, 5 mM EDTA, 50 mM Tris-HC1, pH 8, 0.5 % NP-40, 
0.1%  SDS, 0.01%  NAN3), and then loaded on  12.5%  Laemmii-type SDS 
polyacrylamide gel. 
Results 
To express a  functional furin translation product in mam- 
malian cells, the human furin eDNA, isolated from a hepa- 
toma (HepG2) eDNA library (74), was inserted into a vac- 
cinla  virus  expression vector by  standard  methods  (29). 
Plates of BSC-40 cells were infected either with wild-type 
vaccinia virus (VV:WT), with a vaccinia recombinant con- 
talning the yeast KEX2 gene (VV:KEX2), or with a vaccinia 
recombinant containing the furin eDNA (VV:hFUR). Cells 
were harvested 20 h  after infection and crude membrane 
fractions were prepared. Each sample was analyzed for pro- 
teolytic activity capable of cleaving fluorogenic peptide sub- 
strates  containing  a  pair  of basic  amino  acids.  Endopro- 
teolytic activity capable of cleaving substrates  containing 
LysArg- (Table I) increased 4.9- and 2.3-fold, respectively, 
in cells infected with VV:KEX2 or VV:hFUR.  A  similar 
stimulation was found for cleavage of substrates containing 
-ArgArg- (data not shown). The increased proteolytic activ- 
ity observed in either VV:KEX2 or VV:hFUR infected cells 
was quantitatively associated with the 100,000-g membrane 
pellet. This selective partitioning to cellular membranes is 
consistent with earlier observations for Kex2p in yeast (20, 
22, 45) and for Kex2p expressed in BSC-40 cells (68). 
In  addition  to  its  apparent  substrate  specificity,  furin 
shares other enzymic properties with Kex2p. Kex2p is a ser- 
ine protease that is active at neutral pH, strictly calcium de- 
pendent, and inhibited by only high concentrations of PMSF 
(22, 45; Table I). Similarly, the furin-dependent activity was 
inhibited by EGTA (a calcium chelator) and was active at pH 
Table L  Expression of Kex2p and Furin Activity 
in Mammalian Cells 
Condition 
2  mM  +3 mM  2 mM Ca  ++ 
Virus  Ca  ++  EGTA  + 1 mM PMSF 
HSS  WT  12  32  17 
KEX2  56  15  29 
FUR  18  35  24 
HSP  WT  109  131  45 
KEX2  533  137  295 
FUR  250  110  64 
Media  WT  16  27  21 
KEX2  25  22  24 
FUR  21  23  23 
BSC-40 cells were grown to confluency on 100-mm plates in MEM containing 
10%  fetal  calf  serum.  Parallel  plates  were  infected  with  either  VV:WT, 
VV:KEX2 or VV:hFUR (moi =  5).  At 18 h after infection crude membrane 
fractions were prepared and proteolytic activity was determined using a small 
fluorogenic substrate (boc-Gly-Lys-Arg-MCA) as described in Materials and 
Methods. Values are listed as enzyme  units per milligram  protein. One enzyme 
unit equals 1 tool of substrate converted per minute. Values shown are from 
a  single experiment, but qualitatively similar results were obtained in three 
completely independent trials. HSS, high speed superuatant; lISP, high speed 
pellet. 
7.3  (Table I).  Unlike the yeast prohormone endoprotease, 
however, furin activity appeared to be much more sensitive 
to PMSE Neither Kex2p nor furin activity were detected in 
the culture medium (Table I). 
Aliquots of the supernatant and pellet fractions from the 
samples described in Table I, in addition to control samples 
from mock-infected cells, were resolved by one-dimensional 
SDS gel electrophoresis and furin translation products were 
identified by immunoblotting with specific antibodies (Fig. 
2). A doublet of proteins with the apparent sizes of 90 and 
96 kD, respectively, was detected and was found only in the 
membrane fraction from VV:hFUR infected BSC-40 cells 
(Fig.  2,  lane  6).  These apparent molecular masses  are in 
good agreement with the 87-kD translation product predicted 
by the furin eDNA. No furin was detectable by this method 
Figure  2. Immunodetection of furin. High speed supernatant (lanes 
1, 3, and 5) and pellet (lanes 2, 4, and 6) fractions from BSC-40 
cells either mock-infected (lanes 1 and 2) or infected with VV:WT 
(lanes 3 and 4) or VV:hFUR (lanes 5 and 6) were prepared as de- 
scribed in Table I. PAGE  and immunoblotting were prepared as de- 
scribed in Materials and Methods. In a separate experiment the 
high speed pellet prepared from VV:hFUR-infected BSC-40 cells 
in  the  presence  of  1  mM  PMSF  and'2  #g/nil  leupeptin  was 
resuspended by Dounce homogenization in 0.1 M sodium carbonate 
(pH 11) followed by recentrifugation at 100,000 g. Proteins from 
the high speed carbonate supematant (lane 7) and pellet (lane 8) 
fractions were precipitated with TCA, resolved by gel electrophore- 
sis, furin protein was identified by Western blot analysis as de- 
scribed in Materials and Methods. 
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either mock- or VV:WT infected BSC-40 cells (Fig. 2, lanes 
1-5). 
To establish whether furin is tightly associated with mem- 
branes,  the  100,000-g  pellet prepared in  the presence of 
1 mM PMSF and 2 gg/mi leupeptin from BSC-40 cells in- 
fected with VV:hFUR was extracted with 0.1 M sodium car- 
bonate (pH 11) and resedimented at 100,000 g. Western anal- 
ysis demonstrated that the furin doublet was retained in the 
pellet fraction (Fig. 2, compare lanes 7 and 8), as expected 
for the behavior of an integral membrane protein. 
Because Kex2p-dependent precursor cleavage appears to 
occur in the Golgi apparatus in yeast (34), immunofluores- 
cence microscopy was used to determine the subceUular lo- 
calization of furin in mammalian cells.  Plates of BSC-40 
cells were infected with either VV:WT or VV:hFUR and the 
fixed cells were stained with antifurin antiserum. Cells in- 
fected with VV:hFUR revealed intense perinuclear staining 
(Fig. 3 A). No detectable staining was evident in control cells 
infected with VV:WT (Fig. 3 C). The fixed cells were also 
incubated with rhodamine-coupled wheat germ agglutinin 
(WGA), a specific Golgi compartment marker (28, 73). As 
shown in Fig. 3 B, the pattern of staining by WGA was su- 
perimposable with the localization of furin in BSC-40 cells. 
Thus, as predicted for Kex2p in yeast, furin appears to be 
a  Golgi  compartment-associated  enzyme  in  mammalian 
cells. 
The structural (Fig.  1) and enzymic properties (Table I) 
shared by the yeast KEX2 endoprotease and furin suggested 
that this novel human endoprotease may be responsible for 
processing precursors containing paired basic sites to pro- 
duce mature bioactive products in the  secretory pathway. 
Figure 3. lmmunolocalization of furin. Parallel cultures of BSC-40 cells grown on coverslips were infected with either VV:hFUR (A and 
B ) or VV:WT (C and D) at an moi of 1. AFter 18 h, the cells were fixed in 3 % paraformaldehyde and processed for immunofluorescence 
microscopy as described in Materials and Methods. (A and C). Fluorescein fluorescence (furin antiserum). (B and D). Rhodamine fluores- 
cence (WGA binding). 
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in a large number of endocrine and nonendocrine tissues, re- 
quire endoproteolysis at cleavage sites composed of a dou- 
blet of basic residues. To facilitate identification of authentic 
furin substrates, we examined the cell type specificity of fu- 
fin gene expression. Our initial screening of cell lines indi- 
cated detectable levels of furin transcript in all cell types ex- 
amined  including  AtT-20  (mouse  pituitary  corticotroph), 
BSC-40 (African Green monkey kidney epithelial), GH4C1 
(rat pituitary somato/lactotroph), HeLa (human cervical ep- 
ithelial), HepG2 (human hepatoma), L  (mouse fibroblast), 
NG108-15 (rat glioma x  mouse neuroblastoma hybrid), and 
Rin m5F (rat insulinoma). Fig. 4 shows a comparison of rel- 
ative furin transcript levels in three of these cell lines includ- 
ing  the  cell  line  used  as  a  source  for the  cloned eDNA 
(HepG2) and two cell lines (AtT-20 and BSC-40) previously 
characterized for endogenous precursor protein processing 
capability (67-70).  As  expected, a  4.5-kb furin transcript 
was detected in poly A+ RNA from HepG2 cells, the human 
hepatoma cell line from which the furin eDNA was isolated 
(74) (Fig. 4, lane C). This cell line endogenously expresses 
and processes proalbumin at an -ArgArg- site (1, 36). Only 
very low levels of furin transcript were detected in the mouse 
pituitary corticotroph line, AtT-20 (Fig. 4,  lane A).  These 
cells express high levels of POMC  and efficiently process 
this precursor in the regulated secretory pathway (27) at sev- 
eral sites composed of paired basic amino acids (60). Note 
that a second 3.3-kb RNA band, detected only with the AtT- 
20  RNA,  hybridized to  the  radiolabeled furin probe.  In- 
terestingly,  this  species  is  approximately the  size of PC2 
mRNA (59). Whether this band represents PC2, a different 
furin transcript, or yet another KEX2 homologue expressed 
in endocrine cells remains to be determined.  The highest 
levels  of furin  transcript  were  found  in  BSC-40  cells,  a 
monkey kidney epithelial line (Fig. 4, lane B). These cells 
possess only a constitutive secretory pathway (70) and are 
incapable  of  processing  certain  neuroendocrine  peptide 
precursors  (including  POMC  and  proenkephalin  [67-70]. 
However, BSC-40 cells endogenously express and process 
the transforming growth factor fl precursor (pro-TGF-~) at 
....  ls  (24).  Furthermore, when ex- 
pressed in BSC-40 cells, the nerve growth factor precursor 
(pro-/~-NGF) was cleaved at a basic residue doublet (Lys  ll9- 
Arg t2°, Fig.  5  A)  to  produce  mature/~-NGF  (19).  One 
potential role, therefore, of the furin endoprotease in mam- 
malian cells is to process growth factor precursors (as op- 
posed to neuropeptide precursors). 
A vaccinia virus recombinant that directs expression of  the 
mouse pro43-NGF eDNA (VV:mNGF) was constructed to 
study the processing of this precursor protein by furin in the 
mammalian  cell  secretory  pathway.  BSC-40  cells  were 
selected since this cell line was used to document vaccinia- 
derived furin expression (Table I; Figs. 2 and 3), possesses 
only the constitutive secretory pathway (70) and is amenable 
to infection with multiple vaccinia recombinants (68). 
Replicate plates of BSC-40 cells were infected with either 
VV:WT or VV:mNGF or both, and at increasing times after 
virus infection each culture was metabolically labeled for 
3  h  with [35S]methionine.  The secreted products were im- 
munoprecipitated with pooled monoclonal antibodies direct- 
ed against/3-NGF and resolved by SDS gel electrophoresis. 
In agreement with earlier studies (19), metabolic labeling of 
BSC-40 ceils at short times after infection (3 h) resulted in 
expression of pro-/3-NGF and efficient processing of the pro- 
hormone to mature 13-kD/3-NGF peptide, presumably by 
Figure  4.  Analysis  of  furin 
mRNA.  5  /~g of poly A  ÷ RNA 
isolated from AtT-20 (A),  BSC- 
40  (B),  and  HepG2  (C)  cells 
was  denatured  with  formalde- 
hyde, subjected to electrophore- 
sis  in  a  1%  agarose  gel,  trans- 
ferred  to  a  nylon  membrane 
(Hybond-N;  Amersham  Corp., 
Arlington Heights, IL), and hy- 
bridized  with  a  random-prime 
32p-labeled insert containing the 
hfur cDNA sequence. After ex- 
posure to x-ray film, the blot was 
stripped and rehybridized with a 
random-primed 32p-labeled probe 
of the  1B15 (cyclophilin) sequence to ensure that equal levels of 
RNA were loaded initially, hfurin mRNA migrates at 4.5 kb. 11315 
migrates at 1 kb. 
Figure 5. Processing of pro-~-NGF by Kex2p and furin in vivo. (A) 
Schematic of pro-/3-NGF expressed from VV:mNGF vector (14), 
with cleavage sites at paired basic amino acids (vertical bars) and 
mature  /3-NGE (B)  Immunoprecipitation  of /J-NGF from the 
medium of BSC-40 cells infected with (/) VV:WT +  VV:mNGE 
(2) VV:KEX2 + VV:mNGE or (3)VV:hFUR + VV:mNGE Im- 
munoprecipitations were performed as described in Materials and 
Methods using an equal volume of media from equal amounts of 
cells. Pro-/3-NGF migrates as a 35--40-kD band, whereas mature 
/$-NGF migrates as a 13-kD band. Processing intermediates appear 
at 18 and 20 kD. 
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ing was initiated at a later time (19-h postinfection), the rate 
of pro-/~-NGF synthesis was significantly  higher and the ma- 
jor secreted product was unprocessed precursor (Fig. 5 B, 
lane/). This observation provided a means to examine the 
effect of elevated furin protease activity on the efficiency of 
processing of pro-/~-NGE 
Either Kex2p or furin was coexpressed with pro-/~-NGF 
in BSC-40 cells.  18 h after infection, each sample was in- 
cubated for 3 h with [35S]methionine and/3-NGF-containing 
peptides were immunoprecipitated from the culture media 
using pooled monoclonal antibodies directed against/3-NGE 
Under  these  conditions,  coexpression  of Kex2p  together 
with pro-/3-NGF  markedly increased processing of pro-/~- 
NGF to mature (13 kD) fl-NGF peptide (Fig. 5 B, lane 2). 
In addition, two peptides of 18 and 20 kD were also immuno- 
precipitated. These peptides probably represent processing 
intermediates resulting from cleavage within the proregion 
of the precursor (32).  Thus, Kex2p, which can efficiently 
process mouse POMC in mammalian cell (68), also can pro- 
cess pro-/~-NGF to/3-NGF peptide. Strikingly, coexpression 
of human furin and pro-/~-NGF resulted in complete conver- 
sion of pro-B-NGF  to  smaller peptides,  primarily  13-kD 
~-NGF (Fig. 5 B, lane 3). As a control to ensure that the ap- 
parent pro-/3-NGF  processing was not occurring in the me- 
dium after secretion, labeled pro-/3-NGF  from the culture 
medium of VV:mNGF-infected cells was transferred to plates 
of either VV:WT- or VV:hFUR-infected cells. Analysis of 
this material after 3 h of incubation demonstrated that pro- 
/~-NGF was completely stable in the culture medium. 
Comparison of  the 13-kD ~-NGF to 35-kD pro-/~-NGF by 
densitometric analysis revealed that in the sample from cells 
coinfected with VV:mNGF and VV:WT,  only 23%  of the 
radioactivity was present as 13-kD/$-NGF; in marked con- 
trast in cells coinfected with VV:mNGF and VV:KEX2 or 
VV:hFUR,  the fraction of radioactivity present as  13-kD 
/$-NGF was 79 and >98%, respectively. The processed NGF 
in the medium from cells coinfected with VV:mNGF and 
VV:hFUR was biologically active as determined by its abil- 
ity to induce neurite outgrowth on chick dorsal root ganglia, 
whereas  medium from cells  infected with VV:WT  alone 
was negative for this biologic activity (Bresnahan, P., and 
G.  Thomas,  unpublished  results).  Because  the  vaccinia- 
produced furin activity measured by in vitro assay of the in- 
fected cells was substantially lower than vaccinia produced 
Kex2p activity (Table  I),  yet pro-/~-NGF  conversion was 
complete in the furin producing ceils but not in the Kex2p- 
producing cells, the human endoprotease appears to be a 
more efficient processing enzyme for this precursor in BSC- 
40 cells. 
Discussion 
Our results demonstrate that the human furin cDNA isolated 
from HepG2 cells encodes a Golgi compartment-localized 
membrane-associated, calcium-dependent, serine protease. 
In agreement with the reported structural homology between 
furin and the yeast KEX2  prohormone endoprotease (23, 
72), we show that both enzymes share significant functional 
homology in vitro (Table I) and in vivo (Fig. 5). 
The Western blot analysis in Fig. 2 revealed two prominent 
furin translation products (90 and 96 kD) present in crude 
membrane  fractions of VV:hFUR-infected BSC-40  cells. 
The cause of the size heterogeneity is not yet known. One 
possibility is that the doublet may result from heterogeneity 
in posttranslational modifications (e.g., note in Fig.  1 the 
multiple sites for attachment of asparagine-linked sugars). 
However,  the doublet is  still present after treatment with 
N-glycanase (74). A second possibility is that the initial furin 
translation product is actually an inactive zymogen which 
becomes activated by endoproteolytic cleavage.  Indeed, au- 
toproteolytic removal of the entire amino terminal extension 
is required for activation of the structurally related bacterial 
subtilisin precursor  (30,  50).  Similarly, the  precursor  of 
Kex2p protease undergoes removal of an NH2-terminal  pro- 
peptide, probably by an autoproteolytic mechanism (Wilcox, 
C. A., and R. S. Fuller, personal communication). The furin 
cDNA  sequence predicts  a  small cluster of paired basic 
amino acids at nearly the identical position as found in KEX2. 
Cleavage at either of these sequences would generate a pro- 
tein ,o6 kD smaller than the primary translation product (the 
same size difference detected in Fig. 2). The observed dou- 
blet is not likely to be merely an artifact of sample prepara- 
tion because it was found when harvesting in the presence 
of protease inhibitors (Fig. 2) or when the cells were ex- 
tracted directly with buffer containing 2%  SDS  at 70°C 
(Leduc, R., and G. Thomas, unpublished results). 
The preferential localization of furin to the Golgi appara- 
tus of BSC-40 cells (Fig. 3) suggests conserved mechanisms 
for intracellular targeting of processing proteases between 
yeast and humans. IntraceUular retention of Kex2p in the 
Golgi apparatus of Saccharomyces cerevisiae is required for 
efficient maturation of a-mating factor. Yeast mutants lack- 
ing clathrin heavy chain are unable to retain Kex2p intracel- 
lularly, resulting in deficient processing of the pro-a-mating 
pheromone (48).  Similarly, deletions of the Kex2p cytoplas- 
mic tail also result in mislocalization of the protease and 
inefficient processing of the pro-cr-mating  pheromone (23). 
The observation that both Kex2p and furin share a highly 
charged  cytoplasmic  tail,  including  conserved  tyrosine 
residues (23,  72),  suggests that the furin cytoplasmic tall 
may also be required for retention of this protease in the 
Golgi compartment. Golgi compartment localization of fu- 
rin in our experiments is unlikely to be an artifact of over- 
production of the protein because several other proteins of 
known subcellular localization reach their proper destination 
when produced from vaccinia expression vectors. For exam- 
ple,  in  polarized epithelial  cells,  VSV-G protein  and in- 
fluenza virus HA antigen are correctly targeted to the baso- 
lateral and apical membranes, respectively, when expressed 
by vaccinia virus recombinants (65).  Likewise, addition of 
the KDEL endoplasmic retention signal onto a soluble form 
of  CD4 expressed from vaccinia confers retention of  this pro- 
tein to the ER (7).  The actual compartment in which furin- 
directed proteolysis occurs remains to be determined. How- 
ever, the apparent localization to the Golgi compartment and 
substrate specificity of this endoprotease correlates with the 
reported endoproteolysis of several retroviral envelope pro- 
teins (including RSV Pr95 [49] and HIV gpl60 [63]), which 
apparently requires a  -LysArg- directed endoprotease and 
takes place in the Golgi apparatus. 
Processing of peptide precursors at pairs of basic residues 
has been studied most extensively in endocrine cell lines 
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is restricted to the regulated secretory pathway (8, 27, 35). 
When missorted into the constitutive secretory pathway, pro- 
hormone molecules are not processed, but secreted as the in- 
tact precursor (27, 70). However, processing of other precur- 
sor proteins at doublets of basic residues occurs in cells that 
lack  the  regulated  secretory  pathway  (e.g.,  BSC-40,  L, 
HeLa) including pro-/3-NGF (19; Fig.  5), pro-TGF-~ (58), 
proalbumin (1, 36), pro-von Willebrand factor (5, 74), insu- 
lin proreceptor (76), and several retroviral envelope proteins 
(e.g.,  HIV gpl60)  (43, 49, 51, 52).  The widespread tissue 
distribution of this large class of precursor proteins suggests 
that the cognate endoprotease(s)  must also be present in a 
wide variety of tissue and cell types.  Consistent with these 
findings,  furin mRNA is found ubiquitously in all cultured 
cell  lines  tested, although markedly  different levels  of ex- 
pression  are  observed  (Fig.  4;  and  Thomas,  L.,  and  G. 
Thomas, unpublished results). 
While both prohormone (e.g.,  POMC) and other precur- 
sors (e.g.,  pro-/3-NGF)  require proteolysis  at paired basic 
amino acids to liberate biologically active polypeptl.des, the 
dependence of prohormone processing on localization to the 
regulated secretory pathway suggests a specific mechanism 
for maturation of this class of substrate. This restriction may 
arise from: (a) structural differences in the precursor mole- 
cules, including sequences in the vicinity of the processing 
site or higher order structural properties (e.g.,  folding); (b) 
differential  compartmentalization  of the  substrate  and the 
processing enzyme(s); or, perhaps, (c) expression of distinct 
processing enzymes in the regulated pathway.  One notable 
structural  similarity  shared by several  "nonhormone" sub- 
strates,  including the precursors  for factor IX  (3),  insulin 
receptor  (76),  endothelin  (75),  TGF-~  (58),  EGF  (26), 
/5-NGF (4), brain-derived neurotropic factor (BDNF) (38), 
neurotrophin 3 (42), and HIV gpl60 (43), is an arginine lo- 
cated four residues amino-terminal to the paired basic cleav- 
age site (-Arg-X-Lys/Arg-Arg-).  The lack of processing of a 
mutant  pro-factor  IX  (Arg-Pro-Lys-Arg-~  -Gln-Pro-Lys- 
Arg-) suggests that this residue is required (3). In contrast, 
the  neuroendocrine  prohormone,  prosomatostatin,  is  not 
processed in fibroblasts (57) even though it possesses an ar- 
ginine residue four amino acids amino-terminal to the paired 
basic cleavage site. However, the apparent processing site on 
prosomatostatin is an -Arg-Lys- sequence,  not -LysArg- or 
-ArgArg- typically found in nonhormone precursors. Muta- 
tion of this -ArgLys- site in prosomatostatin to -ArgArg- or 
-LysArg- results in a partial processing of this prohormone 
in fibroblast ceils (66) suggesting that -ArgArg- or -LysArg- 
are indeed the preferred sites for the processing enzyme in 
the constitutive pathway,  presumably furin. 
Consistent with this view,  using pro-~-NGF  as a model 
substrate, we demonstrated that furin expressed in a recom- 
binant vaccinia  vector  ett~cienfly  processed  a  mammalian 
precursor protein in the constitutive  secretory  pathway of 
BSC-40 cells. Taken together, the results presented here un- 
equivocally identify furin as the initial member of a unique 
family of mammalian proteases capable of processing pre- 
cursor proteins in the secretory pathway. 
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